Financial Disclosure Statement

Axel Ducret
F. Hoffmann-La Roche Ltd

MSACL 2015 EU Abstract Title:
Quantification of Human Receptor Tyrosine-protein Kinase ErbB-2 (HER2) by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue

DescriptionY/NSource
Grantsno
SalaryyesF. Hoffmann-La Roche Ltd
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no